Imunon, Inc. Acquisitions, Net of Cash Acquired
Imunon, Inc. (IMNN) reported Acquisitions, Net of Cash Acquired of $2.82 million for the 12-month period ending 2014-12-31, per its 10-K filed 2016-03-30.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2016-03-30
- Imunon, Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2014-12-31 was -$29.11K.
- Imunon, Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2014-09-30 was $28.91K.
- Imunon, Inc. payments to acquire businesses, net of cash acquired for fiscal 2014 was $2.82M.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|
| 2014-12-31 | -$29.11K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$200.00 derived: sum of 2 quarters · filed 2016-03-30 | $2.82M 10-K · filed 2016-03-30 | |
| 2014-09-30 | $28.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $2.85M 10-Q · filed 2015-11-05 | ||
| 2014-06-30 | $2.82M 10-Q · filed 2015-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |